SCHEMBL2391709

SCHEMBL2391709

O=C(O)C(F)c1ccccc1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
FGFR1 P11362 2/20 0.43
FGFR2 P21802 2/20 0.43
FGFR4 P22455 2/20 0.43
FGFR3 P22607 2/20 0.43
BCAT2 O15382 1/20 0.42
PTGS2 P35354 3/20 0.42
PTPRC P08575 1/20 0.41
PTPRF P10586 1/20 0.41
PTPN1 P18031 1/20 0.41
CDC25B P30305 1/20 0.41
SRC P12931 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
CASP1 P29466 1/20 0.41
PTGS1 P23219 3/20 0.40
MEN1 O00255 3/20 0.40
HPGD P15428 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2391431 0.89 SLC6A4 (0.45) KMT2APTGS2PTGS1ALDH1A1BCL2L1
SCHEMBL2389486 0.86 MAOB (0.46) PTGS2PPARAPPARG
SCHEMBL2393686 0.85 BCAT2 (0.48) KMT2AFGFR1FGFR2FGFR4FGFR3
SCHEMBL2389641 0.84 HSP90AA1 (0.47) KMT2APTGS2PTPRCHSP90AA1HSP90AB1
SCHEMBL2391552 0.81 NPSR1 (0.47) KMT2APTPRCPTPN1MEN1HPGD
SCHEMBL9890795 0.80 FGFR1 (0.46) KMT2AFGFR1FGFR2FGFR4FGFR3
SCHEMBL4120437 0.79 KMT2A (0.50) KMT2AFGFR1FGFR2FGFR4FGFR3
SCHEMBL29385679 0.79 KMT2A (0.50) KMT2AFGFR1FGFR2FGFR4FGFR3
SCHEMBL4886483 0.78 LMNA (0.50) KMT2AFGFR1FGFR2FGFR4FGFR3
SCHEMBL4873147 0.76 TRPA1 (0.46) KMT2ABCAT2PTGS2PTPRCPTPRF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-54112842-A None JP disclosed
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-06-07 US disclosed
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-06-07 US disclosed
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-06-07 US disclosed
EP-2374790-A1 BIPHENYLACETAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2011-10-12 EP disclosed
EP-2374790-A1 BIPHENYLACETAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2011-10-12 EP disclosed
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-09-15 US disclosed
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-09-15 US disclosed
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-09-15 US disclosed
WO-2010055911-A1 BIPHENYLACETAMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2010-05-20 WO disclosed
JP-S54112842-A PREPARATION OF ALPHA-BIPHENYLYL-PROPIONIC ACID DERIVATIVE NIKKEN KAGAKU KK 1979-09-04 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE HRH3, KCNH3, BRPF3 KMT2A 78/4885FGFR1 294/4885FGFR2 139/4885
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE HRH3, KCNH3, BRPF3 KMT2A 78/4885FGFR1 294/4885FGFR2 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.